Hakim Gizaw Hospital
Debre Berhan, Amhara, 1000, Ethiopia
NCT Number: NCT07171086
Maternal and neonatal health remains one of the most pressing global health challenges, particularly in low- and middle-income countries (LMICs). Ethiopia continues to face a high burden, with maternal mortality estimated at 195 per 100,000 live births, neonatal mortality at 27 per 1,000 live births, and perinatal mortality rates ranging from 37‰ to 124‰ depending on the level of care. These outcomes remain substantially higher than the targets set under the United Nations Sustainable Development Goals (SDGs) for 2030.
The World Health Organization (WHO) recommends that all pregnant women receive at least one ultrasound scan before 24 weeks of gestation, yet nearly two-thirds of women worldwide-especially in LMICs-lack access to this service. Barriers include high costs of ultrasound machines, limited technical expertise, and shortages of skilled sonographers in rural primary care.
Artificial Intelligence-driven Point-of-Care Ultrasound (AI-POCUS) represents a promising innovation to expand prenatal imaging in resource-constrained settings by equipping frontline health workers with AI-supported diagnostic capabilities. This study, conducted under the Tsinghua University BRIGHT (Bringing Research to Impact for Global Health at Tsinghua) program, will evaluate the clinical effectiveness, feasibility, cost, and scalability of AI-POCUS in rural Ethiopia. A three-arm cluster randomized controlled trial will compare two AI-enabled ultrasound technologies-BabyChecker (Netherlands) and a China-developed AI-POCUS device-against standard antenatal care without ultrasound. Findings will generate robust clinical and policy-relevant evidence to guide the sustainable implementation of AI-enabled maternal health interventions in sub-Saharan Africa.
Trial opening soon.
Get Notified15 year–49 year
Female
Interventional
Phase 4
Debre Berhan, Amhara, 1000, Ethiopia
Maternal and neonatal morbidity and mortality remain unacceptably high in sub-Saharan Africa and continue to impede progress toward global health targets. In Ethiopia, recent estimates show maternal mortality at 195 per 100,000 live births and neonatal mortality at 27 per 1,000 live births. Perinatal mortality is also elevated, ranging between 66‰ and 124‰ in hospital-based settings and 37‰ to 52‰ in community-level health facilities. These figures surpass the Sustainable Development Goal (SDG) thresholds for 2030, underscoring the urgent need for innovative, scalable solutions.
Ultrasound imaging is a cornerstone of modern antenatal care. The WHO recommends at least one ultrasound before 24 weeks' gestation to assess gestational age, detect multiple pregnancies, identify fetal anomalies, and diagnose high-risk conditions such as preeclampsia, placenta previa, or growth restriction. However, nearly two-thirds of pregnant women worldwide still lack access to this basic diagnostic tool. In low-resource environments, the barriers include limited infrastructure, high equipment costs, technical complexity, and the scarcity of trained professionals capable of performing and interpreting scans. As a result, potentially preventable maternal and neonatal deaths remain common.
Artificial Intelligence-driven Point-of-Care Ultrasound (AI-POCUS) introduces a transformative opportunity to address these gaps. POCUS devices embedded with AI algorithms can guide non-specialist health workers in image acquisition and interpretation, reducing reliance on highly trained personnel and lowering barriers to integration within primary care. Such innovations may strengthen early detection of pregnancy complications, enable timely referral to higher-level care, and ultimately improve maternal and neonatal survival.
This study is embedded within the Bringing Research to Impact for Global Health at Tsinghua (BRIGHT) initiative. It will use a three-arm cluster randomized controlled trial (C-RCT) design to evaluate and compare: (1) BabyChecker, a portable AI-enabled ultrasound developed in the Netherlands, (2) A China-developed AI-POCUS device, and (3) Standard antenatal care (ANC) without ultrasound, reflecting current practice in many rural Ethiopian communities.
The study population will include pregnant women receiving antenatal care in rural Ethiopia, as well as primary health care providers delivering these services. Data will be collected at both the patient and facility level to capture maternal and neonatal health outcomes, health service utilization, and system-level performance indicators.
Evaluation will follow a multi-dimensional framework, addressing:
The study aims to provide rigorous clinical evidence and practical implementation guidance on how AI-POCUS technologies can be sustainably scaled in resource-constrained settings. Findings are expected to inform national health policies, guide investment decisions, and offer a replicable model for expanding maternal health technologies across sub-Saharan Africa and other LMICs.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
A portable AI-driven ultrasound system developed by Delft Imaging (Netherlands). The device integrates fetal position, amniotic fluid volume, and biparietal diameter measurements, with built-in diagnostic suggestions and risk alerts. Primary healthcare workers, after brief training, use it for antenatal screening, complication detection, and referral decision-making.
An AI-POCUS device developed by Edan (China), capable of analyzing blind ultrasound sweeps to extract fetal diagnostic parameters and assist in early risk identification. It supports clinical decision-making for antenatal care.
Time frame: Baseline through 42 days postpartum
Maternal deaths per 100,000 live births, defined as deaths occurring during pregnancy or within 42 days postpartum due to pregnancy-related causes.
Time frame: Delivery through 7 days postpartum
Stillbirths (≥28 weeks gestation) per 1,000 total births, and perinatal mortality including stillbirths and neonatal deaths within the first 7 days of life.
Time frame: Birth through 7 days postpartum
Neonatal deaths within the first 7 days of life per 1,000 live births.
Time frame: At delivery
Proportion of births before 37 completed weeks of gestation, subdivided into extremely preterm (<32 weeks), very preterm (32-33 weeks), and late preterm (34-36 weeks).
Time frame: Antenatal period through 42 days postpartum
Proportion of mothers or newborns referred to higher-level hospitals due to severe complications.
Time frame: Antenatal period through delivery
Proportion of infants with major structural anomalies detected by prenatal ultrasound or confirmed postnatally (e.g., neural tube defects, limb malformations, cleft lip/palate).
Time frame: Pregnancy through delivery
Proportion of pregnant women who completed at least 4 of 8 ANC visits, respectively, during pregnancy, according to WHO recommendations.
Time frame: Pregnancy through delivery
Proportion of pregnant women identified as high-risk (e.g., placenta previa, malpresentation) by AI-POCUS or conventional ultrasound, divided by total enrolled women.
Time frame: Pregnancy through delivery
Among women identified as high-risk, proportion who completed at least 1 or 2 follow-up ANC visits.
Time frame: Pregnancy through delivery
Proportion of women meeting high-risk pregnancy criteria who successfully completed referral to a higher-level hospital.
Contact information is provided by the study sponsor or research team.
Tsinghua University
Other
AI-POCUS to Improve Maternal and Neonatal Health Outcomes in Rural Ethiopia: A Three-Arm Cluster Randomized Controlled Trial
Acronym: AIM-ETH
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06915428
Abortion, Habitual, Abortion, Spontaneous
Chapel Hill, North Carolina, United States
View Trial DetailsNCT07626112
Assessment of Fetal Movement, Death
Austin, Texas, United States
View Trial DetailsNCT06861309
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Death
Roanoke, Virginia, United States
View Trial DetailsNCT05934318
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases and Pregnancy Complications
Kisumu, Kenya
View Trial Details